<?xml version="1.0" encoding="UTF-8" standalone="no"?><information><Cell><NavigationPath><Head00>Characteristic</Head00><Stub><SubHeader0>ECOG performance statusa</SubHeader0><StubValue>â€ƒ0</StubValue></Stub><HeaderValue>N=41</HeaderValue></NavigationPath><value>17 (41.5%)</value><CellType>Partially Numeric</CellType></Cell><Table><tableName>Baseline patient characteristics</tableName><TableType>Subheader</TableType><tableOrder>Table 2</tableOrder><tableFooter>ECOG, Eastern Cooperative Oncology Group.aThe ECOG performance status of one patient was unknown.</tableFooter></Table><Document><DocumentTitle>Gemcitabine with a specific conformal 3D 5FU radiochemotherapy technique is safe and effective in the definitive management of locally advanced pancreatic cancer</DocumentTitle><PMC>2360339</PMC></Document></information>